In focus
Latest feed
India's Landmark Approval: Wegovy Cleared for MASH, a Serious Liver Condition
Wegovy Gets Green Light in India as First‑Line Treatment for MASH, the Liver Condition Touching One‑Third of Indians
A New Dawn for Thyroid Eye Disease: Viridian Therapeutics' Lumvoa Poised for Transformative Impact
Aurobindo Pharma Secures Landmark USFDA Approval for Generic Tofacitinib: A Game-Changer?
